BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 31350646)

  • 1. Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
    Krug D; Lederer B; Seither F; Nekljudova V; Ataseven B; Blohmer JU; Costa SD; Denkert C; Ditsch N; Gerber B; Hanusch C; Heil J; Hilfrich J; Huober JB; Jackisch C; Kümmel S; Paepke S; Schem C; Schneeweiss A; Untch M; Debus J; von Minckwitz G; Kühn T; Loibl S
    Ann Surg Oncol; 2019 Nov; 26(12):3892-3901. PubMed ID: 31350646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
    Ataseven B; Lederer B; Blohmer JU; Denkert C; Gerber B; Heil J; Kühn T; Kümmel S; Rezai M; Loibl S; von Minckwitz G
    Ann Surg Oncol; 2015 Apr; 22(4):1118-27. PubMed ID: 25297900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
    Miyashita M; Niikura N; Kumamaru H; Miyata H; Iwamoto T; Kawai M; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Tsuda H; Nakamura S; Tokuda Y
    Ann Surg Oncol; 2019 Aug; 26(8):2475-2485. PubMed ID: 31102090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?
    Aurilio G; Bagnardi V; Graffeo R; Nolè F; Petit JY; Locatelli M; Martella S; Iera M; Rey P; Curigliano G; Rotmensz N; Munzone E; Goldhirsch A
    Anticancer Res; 2014 Nov; 34(11):6677-83. PubMed ID: 25368274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
    Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
    Cho WK; Park W; Choi DH; Kim YB; Kim JH; Kim SS; Kim K; Kim JH; Ahn SJ; Lee SY; Lee J; Kim SW; Kwon J; Ahn KJ
    Clin Breast Cancer; 2019 Feb; 19(1):78-86. PubMed ID: 30241965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
    Sanford RA; Lei X; Barcenas CH; Mittendorf EA; Caudle AS; Valero V; Tripathy D; Giordano SH; Chavez-MacGregor M
    Ann Surg Oncol; 2016 May; 23(5):1515-21. PubMed ID: 26678405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.
    Leonardi MC; Tomio L; Radice D; Takanen S; Bonzano E; Alessandro M; Ciabattoni A; Ivaldi GB; Bagnardi V; Alessandro O; Francia CM; Fodor C; Miglietta E; Veronesi P; Galimberti VE; Orecchia R; Tagliaferri L; Vidali C; Massaccesi M; Guenzi M; Jereczek-Fossa BA;
    Ann Surg Oncol; 2020 Mar; 27(3):752-762. PubMed ID: 31732946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.
    Hessler LK; Molitoris JK; Rosenblatt PY; Bellavance EC; Nichols EM; Tkaczuk KHR; Feigenberg SJ; Bentzen SM; Kesmodel SB
    Ann Surg Oncol; 2017 Oct; 24(10):2907-2914. PubMed ID: 28766198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy.
    Lin J; Lin KJ; Wang YF; Huang LH; Chen SL; Chen DR
    BMC Cancer; 2020 May; 20(1):451. PubMed ID: 32434493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
    Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Jung KH; Gong G; Kim HH; Ahn SH; Ko B
    JAMA Surg; 2020 Dec; 155(12):1142-1150. PubMed ID: 33052412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
    Weksberg DC; Allen PK; Hoffman KE; Litton JK; Strom EA; Shah RR; Kuerer HM; Hunt KK; Buchholz TA; Mittendorf EA
    Ann Surg Oncol; 2013 Oct; 20(11):3430-7. PubMed ID: 23720073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
    Monrigal E; Dauplat J; Gimbergues P; Le Bouedec G; Peyronie M; Achard JL; Chollet P; Mouret-Reynier MA; Nabholtz JM; Pomel C
    Eur J Surg Oncol; 2011 Oct; 37(10):864-70. PubMed ID: 21843920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
    Abdel-Rahman O
    Clin Breast Cancer; 2018 Dec; 18(6):504-510. PubMed ID: 30115454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status.
    Zetterlund L; Celebioglu F; Hatschek T; Frisell J; de Boniface J
    Br J Surg; 2021 May; 108(5):583-589. PubMed ID: 34043772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional outcomes in clinical stage IIB breast cancer after neoadjuvant therapy and mastectomy with or without radiation.
    Diaz DA; Hurley J; Reis I; Takita C; Zhao W; Wright J
    Medicine (Baltimore); 2014 Dec; 93(29):e230. PubMed ID: 25546661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hazard models with and without consideration of competing risks to assess the effect of neoadjuvant chemotherapy on locoregional recurrence among breast cancer patients.
    Pathak M; S Deo SNV; Dwivedi SN; Vishnubhatla S; Thakur B
    J Cancer Res Ther; 2021; 17(4):982-987. PubMed ID: 34528552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.